Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Litx (Talaporfin Sodium + LED) vs Standard of Care in Unresectable HCC
NCT00355355Phase 3Completed
- Sponsor
- Light Science Oncology
- Start
- Jul 2006
- Primary completion
- Sep 2012
- Countries
- 11
01
Overview
A Phase 3 trial of talaporfin sodium in hepatocellular carcinoma (HCC), sponsored by Light Science Oncology. Started Jul 2006; status: completed.
02
Drugs
talaporfin sodium
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00355355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00355355.